Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):57–64. doi: 10.1158/1055-9965.EPI-08-0377

Table 1. Pathological descriptors and patient demographics of prostate cancer patient cohort.

The cohort used in this study consisted of 166 cancers from men who had localized peripheral zone cancer. Their pathological descriptors and demographics are listed here.

Total number of patients 166
% Recurrencea 56
Median Range Average
Age Distribution (years) 66 35 – 76 64
Time to Recurrence (days) 256 0 – 3048 1797
PSA values
pre-surgical (ng/ml) 16.4 2 – 266 22.4
at time of recurrencea (ng/ml) 0.2 0.07 – 12 0.72
last PSAb (ng/ml) 0.1 0 – 1366 33.24
Vol. of Largest Cancer (cc) 4.37 0.4 – 45 6.12
Total Cancer Volume (cc) 4.8 0.4 – 45 6.58
Gleason Grade
% Grade 3 60 0 – 98 55.7
% Grade 4 30 2 – 100 36.1
% Grade 5 0 0 – 90 3.9
% Intraductal 0 0 – 60 4.3
% high grade (4/5) tumor 35 2 – 100 40
Prostate weight (g) 46 20 – 366 51.5
a

recurrence as determined by PSA >0.05 ng/mL after prostatectomy

b

last PSA: either at time of death or at the last 5 year follow-up visit